USP37 and breast cancer: Finally, considering that USP37 is overexpressed in breast cancer, small molecules that inhibit USP37 have broad development prospects and a combination of USP37 inhibitor with platinum-based therapy or IR may provide a novel approach for breast cancer therapy.